Gene · 23345
Papers2,274
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,274
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Data mining identifies novel RNA-binding proteins involved in colon and rectal carcinomas. | Front Cell Dev Biol | 2023 | 37384253 | PubTator, text mining | PubMed |
| Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival. | Front Oncol | 2023 | 37377916 | PubTator, text mining | PubMed |
| Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 37373553 | PubTator, text mining | PubMed |
| Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma. | Biology (Basel) | 2023 | 37372093 | PubTator, text mining | PubMed |
| Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes. | Front Oncol | 2023 | 37350936 | PubTator, text mining | PubMed |
| Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma. | Sci Rep | 2023 | 37340028 | PubTator, text mining | PubMed |
| Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma. | Front Oncol | 2023 | 37333810 | PubTator, text mining | PubMed |
| TMX4-driven LINC complex disassembly and asymmetric autophagy of the nuclear envelope upon acute ER stress. | Nat Commun | 2023 | 37311770 | PubTator, text mining | PubMed |
| Histone Modification of Osteogenesis Related Genes Triggered by Substrate Topography Promotes Human Mesenchymal Stem Cell Differentiation. | ACS Appl Mater Interfaces | 2023 | 37310722 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma. | Transl Cancer Res | 2023 | 37304554 | PubTator, text mining | PubMed |
| Expression of pyroptosis-related genes are correlated with immune microenvironment and predict prognosis in ESCA. | J Cancer Res Clin Oncol | 2023 | 37302999 | PubTator, text mining | PubMed |
| ATHENA: an independently validated autophagy-related epigenetic prognostic prediction model of head and neck squamous cell carcinoma. | Clin Epigenetics | 2023 | 37296474 | PubTator, text mining | PubMed |
| The analysis of cathepsin L that mediates cellular SARS-CoV-2 infection leading to COVID-19 in head and neck squamous cell carcinoma. | Front Immunol | 2023 | 37292206 | PubTator, text mining | PubMed |
| Comprehensive analyses of a CD8+ T cell infiltration related gene signature with regard to the prediction of prognosis and immunotherapy response in lung squamous cell carcinoma. | BMC Bioinformatics | 2023 | 37280525 | PubTator, text mining | PubMed |
| Molecular subtypes and tumor microenvironment infiltration signatures based on cuproptosis-related genes in colon cancer. | Front Oncol | 2023 | 37274263 | PubTator, text mining | PubMed |
| Modernising autism spectrum disorder model engineering and treatment via CRISPR-Cas9: A gene reprogramming approach. | World J Clin Cases | 2023 | 37274051 | PubTator, text mining | PubMed |
| Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application. | Front Oncol | 2023 | 37260973 | PubTator, text mining | PubMed |
| Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in gastric cancer. | Sci Rep | 2023 | 37258571 | PubTator, text mining | PubMed |
| Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy. | Oxid Med Cell Longev | 2023 | 37251440 | PubTator, text mining | PubMed |
| Overview of cellular homeostasis-associated nuclear envelope lamins and associated input signals. | Front Cell Dev Biol | 2023 | 37250905 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23345/papers?page=14